Clinical Trial Update: Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates the long-term safety and efficacy of subcutaneous amlitelimab in adults with moderate-to-severe asthma who complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Amlitelimab (amlitelimab)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: ACTIVE_NOT_RECRUITING